Skip to main content
Oxford University Hospitals NHS Foundation Trust
Clinical Haematology

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Haemophilia and thrombosis research

Oxford Haemophilia and Thrombosis Centre is very active in clinical research, participating in many national and international studies.

If you have haemophilia, or other rare conditions, you are very likely to be asked to consider taking part in a study to help improve future treatment. This could range from answering a few questions and/or a single blood test, through to trialling a new treatment over a number of years.

The choice to take part in research is entirely yours. If you prefer not to take part, your decision will be respected by your team and it will not affect the care you receive.

Research areas include:

  • novel non-factor haemophilia treatment
  • selection of viruses for gene therapy in haemophilia
  • long-acting factor treatments
  • joint disease in haemophilia
  • genetics of rare bleeding conditions
  • use of novel oral anticoagulants in cancer patients
  • long-term treatment outcomes of patients with DVT and/or PE.

For a list of current and recent studies within the Oxford Haemophilia and Thrombosis Centre, please see the table at the link below:

Research studies May 2017 (pdf, 224 KB)